Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore
New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatmentSINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an...
Source: malaymail.com